Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Sees Significant Growth in Short Interest

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 79,000 shares, an increase of 143.1% from the March 31st total of 32,500 shares. Based on an average daily trading volume, of 996,300 shares, the days-to-cover ratio is presently 0.1 days.

Ono Pharmaceutical Stock Performance

Shares of OPHLY traded down $0.14 during trading hours on Monday, reaching $3.72. The company had a trading volume of 46,421 shares, compared to its average volume of 410,290. Ono Pharmaceutical has a 12-month low of $3.21 and a 12-month high of $5.20. The firm has a 50 day simple moving average of $3.72 and a 200-day simple moving average of $3.71.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.